Clinical Drug Experience Knowledgebase

atezolizumab (Tecentriq) (2 trials)

bevacizumab (avastin) (4 trials)

carboplatin (paraplatin) (3 trials)

denosumab (prolia) (1 trial)

docetaxel (taxotere) (1 trial)

erlotinib (tarceva) (2 trials)

gemcitabine (gemzar) (1 trial)

pembrolizumab (keytruda) (1 trial)

pemetrexed (alimta) (2 trials)

vinorelbine (navelbine) (1 trial)

afatinib (gilotrif) (1 trial)

alectinib (alecensa) (1 trial)

durvalumab (imfinzi) (1 trial)

ipilimumab (yervoy) (1 trial)

nivolumab (opdivo) (3 trials)

osimertinib (tagrisso) (2 trials)

paclitaxel (taxol) (2 trials)